This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Vivesto Past Earnings Performance

Past criteria checks 0/6

Vivesto's earnings have been declining at an average annual rate of -8.5%, while the Biotechs industry saw earnings growing at 11.8% annually. Revenues have been declining at an average rate of 18.2% per year.

Key information

-8.5%

Earnings growth rate

10.6%

EPS growth rate

Biotechs Industry Growth11.5%
Revenue growth rate-18.2%
Return on equity-61.7%
Net Margin-1,766.0%
Next Earnings Update22 Aug 2024

Recent past performance updates

No updates

Recent updates

No updates

Revenue & Expenses Breakdown

How Vivesto makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BATS-CHIXE:VIVES Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 247-117730
31 Dec 237-129840
30 Sep 232-284860
30 Jun 233-340920
31 Mar 233-351950
31 Dec 223-357960
30 Sep 2213-1401010
30 Jun 2224-991070
31 Mar 2229-1181110
31 Dec 2129-1331240
30 Sep 21-184-348880
30 Jun 21-195-3541080
31 Mar 21-199-3761460
31 Dec 204-2101850
31 Oct 20205-59830
31 Jul 20205-24730
30 Apr 20206-112260
31 Jan 204-1961130
31 Oct 196-167850
31 Jul 199-210600
30 Apr 1910-201520
31 Jan 1914-1541070
31 Oct 1813-1531060
31 Jul 1813-1171060
30 Apr 1812-1181090
31 Jan 1810-1281150
31 Oct 1710-1391260
31 Jul 178-1551350
30 Apr 177-1601390
31 Jan 177-1511390
31 Oct 1616-1371410
31 Jul 1619-1391480
30 Apr 1623-1421560
31 Jan 1626-1391500
31 Oct 1518-1411360
31 Jul 1519-1241220
30 Apr 1519-1171110
31 Jan 1523-1251230
31 Oct 1426-1281290
31 Jul 1428-1201240
30 Apr 1430-1051200
31 Jan 1430-901090
31 Oct 1335-751020
31 Jul 1344-711060

Quality Earnings: VIVES is currently unprofitable.

Growing Profit Margin: VIVES is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: VIVES is unprofitable, and losses have increased over the past 5 years at a rate of 8.5% per year.

Accelerating Growth: Unable to compare VIVES's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: VIVES is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (2.9%).


Return on Equity

High ROE: VIVES has a negative Return on Equity (-61.66%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/07/07 00:39
End of Day Share Price 2024/07/01 00:00
Earnings2024/03/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Vivesto AB is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Camilla OxhamreCarnegie Investment Bank AB
Susie JanaEdison Investment Research
Sean ConroyEdison Investment Research